HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Perrigo restructuring includes consolidation of sales/marketing, fewer distribution centers.

This article was originally published in The Rose Sheet

Executive Summary

PERRIGO CONSOLIDATING SALES, MARKETING AND OPERATIONAL FUNCTIONS under a restructuring plan announced June 20. Citing flattened sales and shrinking profit margins over the past year, the Allegan, MI-based private-label manufacturer said it is undertaking the reorganization in an effort to "increase our focus on delivering greater value to our customers while lowering our costs."

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001787

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel